PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

(Antibody) orientation matters

2012-12-10
(Press-News.org) The orientation of antibody binding to bacteria can mean life or death to the bug, according to a study published in The Journal of Experimental Medicine on December 10th. These findings may help explain why these bacteria cause millions of localized infections, but more serious, systemic blood infections are rare.

Streptococcus pyogenes—the causative agent of strep throat—typically invades the body's mucosal surfaces, including the throat and skin. These invasions are kept in check by Y-shaped immune proteins called antibodies, which attach to the bug via their arm (or "Fab") regions. This exposes the stalk ("Fc") portion of the antibody, which is then recognized by immune cells, allowing them to ingest and kill the bacteria. Certain bacteria, including S. pyogenes, fight back by expressing surface proteins that bind the Fc region of antibodies, rendering them invisible to patrolling immune cells.

The new study by Pontus Nordenfelt of Harvard University and his colleagues at Lund University in Sweden suggests that the bacteria have the upper hand in the mucosa, but the immune system wins out in the blood. The scientists found that antibodies in saliva attached to bacteria primarily via their Fc regions, but in blood the orientation was reversed, resulting in swift killing of the bug by immune cells.

The orientation of binding was dictated by the local antibody concentration—low antibody levels (as in saliva) favored Fc-mediated binding; high antibody levels (as in blood) favored Fab-mediated binding. How this works is not entirely clear, but it's possible that the Fc binding proteins on the bacteria become saturated in the high-antibody environment of the blood, permitting free antibody to bind in the opposite orientation.

### About The Journal of Experimental Medicine The Journal of Experimental Medicine (JEM) is published by The Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists in conjunction with our in-house scientific editors. JEM content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit www.jem.org.

Nordenfelt, P., et al. 2012. J. Exp. Med. doi:10.1084/jem.20120325


ELSE PRESS RELEASES FROM THIS DATE:

To fight incurable metastatic breast cancer, resistance must be broken

2012-12-10
One of the most frustrating truths about cancer is that even when a treatment works, it often doesn’t work for long because cancer cells find ways to resist. However, researchers reporting studies done in mice in the December 11, 2012, issue of Cancer Cell, a Cell Press publication, may have a way to stay one step ahead in the case of aggressive metastatic breast cancer. The findings emphasize the importance of basic cancer biology for advancing treatments that are more effective and less toxic, the researchers say. "We need to gain a better understanding of the wiring ...

Into adulthood, sickle cell patients rely on ER

Into adulthood, sickle cell patients rely on ER
2012-12-10
Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers at Washington University School of Medicine in St. Louis. An analysis of Medicaid data of more than 3,200 patients with sickle cell disease shows that emergency room visits tripled from age 15 to age 24. The research is reported Dec. 10 at the American Society of Hematology's annual meeting, in Atlanta. "There seems to be a breakdown in medical care during the transition from childhood to adulthood," says hematologist Morey A. ...

New studies reveal critical insights to improve care of patients with sickle cell disease

2012-12-10
(ATLANTA, December 10, 2012) – Research unveiling key gaps in continuity of care for sickle cell patients transitioning from pediatric to adult care will be presented this week during the 54th Annual Meeting of the American Society of Hematology (ASH). Sickle cell disease (SCD) is an inherited, chronic blood disorder affecting between 90,000 and 100,000 Americans. Instead of producing healthy red blood cells, individuals with the disease produce abnormal, sickle-shaped cells that cannot easily move through blood vessels and deliver adequate oxygen to the body's tissues ...

Joslin scientists: Brown adipose tissue beneficial for metabolism and glucose tolerance

Joslin scientists: Brown adipose tissue beneficial for metabolism and glucose tolerance
2012-12-10
BOSTON – December 10, 2012 – Joslin Diabetes Center scientists have demonstrated that brown adipose tissue (BAT) has beneficial effects on glucose tolerance, body weight and metabolism. The findings, which may lead to new treatments for diabetes, appear in the upcoming issue of the Journal of Clinical Investigation. Unlike the more prevalent white adipose tissue (WAT or white fat) which stores fat, BAT (or brown fat) burns fat to produce heat. Studies in mice and humans have suggested that BAT also plays a role in regulating body weight and metabolism. This has made ...

Elk bones tell stories of life, death, and habitat use at Yellowstone National Park

Elk bones tell stories of life, death, and habitat use at Yellowstone National Park
2012-12-10
Josh Miller likes to call himself a conservation paleobiologist. The label makes sense when he explains how he uses bones as up-to-last-season information on contemporary animal populations. Bones, he says, provide baseline ecological data on animals complementary to aerial counts, adding a historical component to live observation. In his November cover article for the Ecological Society of America's journal Ecology, he assesses elk habitat use in Yellowstone National Park by their bones and antlers, testing his method against several decades of the Park Service's meticulous ...

New multiple myeloma drug shows promise in treating people with advanced disease

2012-12-10
A new oral agent under review by the U.S. Food and Drug Administration (FDA) is safe and effective in treating relapsed and treatment-resistant multiple myeloma, according to a multicenter, Phase II study presented by Mount Sinai School of Medicine researchers at the American Society of Hematology (ASH) Annual Meeting. The meeting is taking place December 8-11, 2012 in Atlanta. A multi-center research team evaluated 113 patients with multiple myeloma who had received at least two prior therapies and had subsequent disease progression to determine safety and efficacy of ...

Morning vs nighttime replacement affects adverse events with extended-wear contact lenses

2012-12-10
Philadelphia, Pa. (December 10, 2012) - For people using 30-day extended-wear/continuous-wear (EW/CW) contact lenses, replacing lenses at night doesn't lower the risk of complications compared to changing lenses monthly, suggests a study – "The Effect of Daily Lens Replacement During Overnight Wear on Ocular Adverse Events", appearing in the December issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part ofWolters Kluwer Health. In contrast, replacing lenses every ...

Face transplantation calls for 'reverse craniofacial planning'

2012-12-10
Philadelphia, Pa. (December 10, 2012) - As surgical teams gain experience with facial transplantation, a careful approach to planning based on the principles of craniofacial surgery can help to maximize patient outcomes in terms of facial form and function, according to an article in The Journal of Craniofacial Surgery. The journal, under the editorship of Mutaz B. Habal, MD, is published by Lippincott Williams & Wilkins, a part ofWolters Kluwer Health. In patients with extensive facial defects including loss of the normal bone and soft tissue landmarks, a "reverse craniofacial ...

Survey shows breakthrough medical research relies heavily on NIH funding

2012-12-10
(ATLANTA, December 10, 2012) – A survey highlighting the correlation between today's cutting edge medical research and the National Institutes of Health (NIH) funding was released today at the 54th Annual Meeting of the American Society of Hematology (ASH), the preeminent medical meeting for physicians and scientists in hematology that draws more than 20,000 attendees from around the world. The survey, representing responses from 1,040 abstract presenters from the U.S. and abroad, demonstrates how critical NIH funding has been to the success of science and medicine. "Every ...

The image of mental fatigue

2012-12-10
We all perhaps know the feeling of mental exhaustion, but what does it mean physiologically to have mental fatigue? A new study carried out using brain scans could help scientists uncover the neurobiological mechanisms underlying mental fatigue. According to Bui Ha Duc and Xiaoping Li of the National University of Singapore writing in a forthcoming issue of the International Journal Computer Applications in Technology, mental fatigue has become commonplace as many people face increasing mental demands from stressful jobs, longer working hours with less time to relax and ...

LAST 30 PRESS RELEASES:

Cost of copper must rise double to meet basic copper needs

A gel for wounds that won’t heal

Iron, carbon, and the art of toxic cleanup

Organic soil amendments work together to help sandy soils hold water longer, study finds

Hidden carbon in mangrove soils may play a larger role in climate regulation than previously thought

Weight-loss wonder pills prompt scrutiny of key ingredient

Nonprofit leader Diane Dodge to receive 2026 Penn Nursing Renfield Foundation Award for Global Women’s Health

Maternal smoking during pregnancy may be linked to higher blood pressure in children, NIH study finds

New Lund model aims to shorten the path to life-saving cell and gene therapies

Researchers create ultra-stretchable, liquid-repellent materials via laser ablation

Combining AI with OCT shows potential for detecting lipid-rich plaques in coronary arteries

SeaCast revolutionizes Mediterranean Sea forecasting with AI-powered speed and accuracy

JMIR Publications’ JMIR Bioinformatics and Biotechnology invites submissions on Bridging Data, AI, and Innovation to Transform Health

Honey bees navigate more precisely than previously thought

Air pollution may directly contribute to Alzheimer’s disease

Study finds early imaging after pediatric UTIs may do more harm than good

UC San Diego Health joins national research for maternal-fetal care

New biomarker predicts chemotherapy response in triple-negative breast cancer

Treatment algorithms featured in Brain Trauma Foundation’s update of guidelines for care of patients with penetrating traumatic brain injury

Over 40% of musicians experience tinnitus; hearing loss and hyperacusis also significantly elevated

Artificial intelligence predicts colorectal cancer risk in ulcerative colitis patients

Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the US

Calibr-Skaggs and Kainomyx launch collaboration to pioneer novel malaria treatments

JAX-NYSCF Collaborative and GSK announce collaboration to advance translational models for neurodegenerative disease research

Classifying pediatric brain tumors by liquid biopsy using artificial intelligence

Insilico Medicine initiates AI driven collaboration with leading global cancer center to identify novel targets for gastroesophageal cancers

Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer

A “smart fluid” you can reconfigure with temperature

New research suggests myopia is driven by how we use our eyes indoors

Scientists develop first-of-its-kind antibody to block Epstein Barr virus

[Press-News.org] (Antibody) orientation matters